Article: CVS Caremark Praises FTC Report Supporting Pro-Consumer Approach to Biogeneric Competition

To: RETAILING EDITORS

Contact: Christine Cramer, +1-401-770-3317, ckcramer@cvs.com, or Steve Campanini, +1-401-770-5005, slcampanini@cvs.com, both Corporate Communications of CVS Caremark

WOONSOCKET, R.I., June 11 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today applauded a Federal Trade Commission (FTC) report issued this week for its pro-consumer leadership in the debate about how to create a legislative pathway for the approval of biogenerics that reasonably balances innovation with competition.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO)

Dave Golding, R.Ph., Executive Vice President for Specialty Pharmacy services at CVS Caremark, participated in an FTC Roundtable ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!